Skip to main content

PACS Group, Inc.

PACS
Exchange
NYSE
Industry
Services-Skilled Nursing Care Facilities
SEC CIK
0002001184

In the last 90 days, PACS Group, Inc. insiders filed 0 open-market purchases and 22 sales; 241 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 10, 2026
$7.79B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $81.8M in total
22
13F holdersQ2 2026, +25 vs. previous quarter
241
13F valueReported value at the end of Q2 2026
$2.11B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$5.29B
+29.3% year over year
Net income, FY2025
$191.5M
+243.5% year over year
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$1.50B
+11.5% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.29M
Shares sold short
Change
−41.3K
−1.0% vs. previous
Days to cover
5.10
At average daily volume

Superinvestors holding PACS, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PACS at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by PACS Group, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 9, 2026 (view filing)6:03 PM ETNov 54 daysMurray Jason HulseCo-Founder, CEO & ChairmanSSale−19.2K$50.64−$974.0K0.0%53.9M after2 lots10b5-1
Nov 4, 2026 (view filing)6:01 PM ETNov 4Same dayLewis Michelle ReneeChief Accounting OfficerSSale−3.17K$50.06−$158.8K−0.9%340.3K after10b5-1
Nov 4, 2026 (view filing)6:01 PM ETNov 2-42 daysMurray Jason HulseCo-Founder, CEO & ChairmanSSale−225.3K$49.21−$11.1M−0.4%54.0M after10 lots10b5-1
Nov 4, 2026 (view filing)6:00 PM ETNov 4Same dayHancock MarkDirector, 10% OwnerSSale−186.7K$50.45−$9.42M−0.3%53.3M after2 lots10b5-1
Oct 30, 2026 (view filing)7:01 PM ETOct 28-292 daysLewis Michelle ReneeChief Accounting OfficerSSale−11.8K$50.11−$592.6K−3.3%343.5K after2 lots10b5-1
Oct 30, 2026 (view filing)7:01 PM ETOct 28-292 daysMurray Jason HulseCo-Founder, CEO & ChairmanSSale−8.80K$50.09−$440.9K0.0%54.2M after2 lots10b5-1
Oct 30, 2026 (view filing)7:00 PM ETOct 28-292 daysHancock MarkDirector, 10% OwnerSSale−13.3K$50.08−$666.2K0.0%53.5M after2 lots10b5-1
Oct 26, 2026 (view filing)6:04 PM ETOct 22-234 daysMurray Jason HulseCo-Founder, CEO & ChairmanSSale−82.6K$48.42−$4.00M−0.2%54.2M after3 lots10b5-1
Oct 21, 2026 (view filing)6:00 PM ETOct 19-212 daysMurray Jason HulseCo-Founder, CEO & ChairmanSSale−45.7K$47.64−$2.18M−0.1%54.3M after3 lots10b5-1
Oct 16, 2026 (view filing)6:01 PM ETOct 142 daysJergensen JoshuaPresident & COOSSale−40.0K$44.50−$1.78M−1.6%2.46M after10b5-1

Top 10 13F holders, Q2 2026

See all 241 holders

The largest institutional positions in PACS Group, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding PACS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Cohen & Steers, Inc.8,343,381$355.8M0.56%−779,755−8.5%Reduced
FMR LLC6,207,375$264.7M0.01%+959,483+18.3%Added
BlackRock, Inc.4,155,408$177.2M0.00%+380,118+10.1%Added
Crewe Advisors LLC3,307,188$141.0M10.22%+553,009+20.1%Added
American Century Companies Inc3,108,196$132.5M0.06%+1,298,565+71.8%Added
Ameriprise Financial Inc1,995,116$85.1M0.02%+873,727+77.9%Added
Vanguard Portfolio Management LLC1,982,621$84.5M0.00%+121,415+6.5%Added
Vanguard Capital Management LLC1,843,496$78.6M0.00%+38,906+2.2%Added
Alyeska Investment Group, L.P.1,539,065$65.6M0.17%−1,463,606−48.7%Reduced
Dimensional Fund Advisors LP1,230,728$52.5M0.01%+450,569+57.8%Added

Holders of 5% or more of PACS

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of PACS Group, Inc..

Largest holders of PACS from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Hancock Mark13G/A35.20%54.6M shares–Nov 14, 20242 filingsFeb 13, 2025SEC
Murray Jason Hulse13G/A35.20%54.6M shares–Nov 14, 20242 filingsFeb 13, 2025SEC